R&D + Strategic Partnering
for the Global Vaccine Industry

Dr. Karen Acker is an Assistant Professor in Clinical Pediatrics at Weill Cornell Medicine and Pediatric Hospital Epidemiologist at NYP/ Komansky Children’s Hospital. After completing her fellowship in pediatric infectious diseases at Columbia University Medical Center in 2018, she joined the...

Dr. Angelidou is a Board-certified Neonatologist at Beth Israel Deaconess Medical Center (Boston, MA), Principal Investigator and Clinical Lead at the Precision Vaccines Program (PVP) in Boston Children’s Hospital, and Assistant Professor in Pediatrics at Harvard Medical School. She obtained her...

Dr. Irnela Bajrovic received her PhD in pharmaceutical sciences from the University of Texas at Austin. Her graduate work established the viability of the thin film technology as a superior method of vaccine stabilization, which bypasses cold-chain maintenance and has the potential to simplify the...

Georges C. Benjamin, MD, is a well-known health policy leader, practitioner, and administrator. He currently serves as the executive director of the American Public Health Association, the nation's oldest and largest organization of public health professionals. He is also a former secretary of...

Dr. Maria Elena Bottazzi is an internationally recognized tropical and emerging disease vaccinologist, global health advocate and cocreator of a patent-free, open science COVID-19 vaccine technology that led to the development of Corbevax in India and IndoVac in Indonesia, and with approximately...

Michelle Brown MD PhD Vice President, Portfolio Lead, Oncology, Moderna     Michelle Brown, MD PhD, obtained her dual degree and post-doctoral training from the University of Utah and Huntsman Cancer Institute with focus on understanding the mechanisms of oncogenesis in pediatric oncology. As a...

Alison Buttenheim is Professor of Nursing and Health Policy at the University of Pennsylvania, where she co-directs the Behavioral Economics and Global Health Insights (BEGIN) Lab and serves as Behavioral Design Lead for the Center for Health Incentives and Behavioral Economics. Her research...

Lee-Jah joined AZ in 2021 and currently is the Vice President, Head of Clinical Development for V&I where he leads the Early and Late V&I clinical teams supporting the clinical development strategy for our vaccine and monoclonal antibody programs. Previously, he was the Head of Early...

Dr. Christensen was recently appointed as Global Head of R&D for Adjuvant Systems at Croda Pharma after 18 years in adjuvant research at Statens Serum Institut, Denmark. During his career, his research focus has been on pharmaceutical and immunological aspects of vaccine adjuvants and delivery...

Colonel Matthew G. Clark is the Joint Project Manager for Chemical, Biological, Radiological, and Nuclear Medical (JPM CBRN Medical). He is responsible for leading themedical portfolio for the Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND). ...

Dr. Cooke has over thirty years of experience in the vaccine industry.  He was previously CEO of NovaDigm Therapeutics, CEO of Mojave Therapeutics, COO at AVANT Immunotherapeutics and SVP at Ology Bioservices. Prior to his leadership roles in the biotechnology industry, he held several positions at ...

Mark A. Emalfarb is the founder and CEO of Dyadic, as well as a member of its Board of Directors. Since founding Dyadic in 1979, he has led its transformation from producing ingredients for stone-washing jeans to developing and commercializing specialty enzymes and the proprietary C1 fungal...

Dr. Faissol is the Principal Investigator of the Generative Unconstrained Intelligent Drug Engineering program, which focuses on the computational design of antibodies and antigens at Lawrence Livermore National Laboratory. His primary research interest is in developing and integrating methods in...

Bill Falstich is Vice President of Pfizer’s Primary Care Category Global Supply Chain. His team of 50 colleagues manages supply for some of the world’s largest vaccines, a broad Internal Medicines portfolio, and Pfizer’s Paxlovid antiviral. His team also plays a critical role in the...

Swati Gupta, DrPH, MPH, leads IAVI’s Emerging Infectious Disease product portfolio and the development of the organization’s overall scientific strategy. She has a particular focus in leveraging IAVI’s recombinant vesicular stomatitis virus (rVSV) platform and expertise to expand product...

Davidson Hamer, MD is a Professor of Global Health and Medicine at the Boston University Schools of Public Health and Medicine, the co-lead of the climate change and emerging infectious diseases research core at the BU Center on Emerging Infectious Diseases, and an attending physician in infectious ...

Professor Dame Jenny Harries is the first Chief Executive of the UK Health Security Agency, an equity-focused executive agency of the Department of Health and Social Care established in October 2021. The Agency's remit is to protect the nation from external hazards to health, including...

Renee Hart serves as the President and Chief Business Officer of LumaCyte, bringing over 25 years of executive experience in life sciences operations and business leadership. Her broad and deep experience and diverse expertise across clinical development, commercialization strategies, bioanalytical ...

Professor Adrian V. S. Hill FRCP, FRS is the Director and Founder of the Jenner Institute, and Mittal Professor of Vaccinology at Oxford University. He is a passionate believer in the power of molecular medicine to address many of the most egregious health care inequities globally. His group have...

Richard Hughes IV, J.D., M.P.H. is a Partner at the Washington, D.C. health care law firm, Epstein, Becker & Green and a Professorial Lecturer in Law at the The George Washington University Law School. His practice, teaching and thought leadership focus on access to preventive health...

As the Government Affairs Director, Lecia Imbery is responsible for developing and implementing effective policy and government affairs strategies and campaigns in support of Vaccinate Your Family’s strategic goals, mission, and vision. Lecia brings with her more than 20 years of experience in...

Ashley is the Founder and CEO of Torigen Pharmaceuticals—a startup that resulted from her graduate thesis project at the University of Notre Dame. Ashley graduated from the University of Connecticut in 2012 with an undergraduate degree in Pathobiology and then chose to continue her...

Dr. Klein is a Professor of Molecular Microbiology & Immunology, Biochemistry & Molecular Biology, and International Health at the Johns Hopkins Bloomberg School of Public Health and Department of Medicine at the Johns Hopkins School of Medicine. She co-directs the Johns Hopkins Center for...

A passionate believer in science and the value vaccines bring to society, Charles leads a team of talented CMC scientists focused on commercial supply of vaccines, as well as supporting efforts in vaccine development and regulatory advocacy.  Working in the vaccines industry since 1995, and within...

Mahesh Kumar has over 35 years in the research and development of vaccines. Starting in the deverlopment of avian vaccines, he now oversees the global vaccines portfolio for all species at Zoetis, the worlds largest animal health company. His interests lie in immunology, vaccines and emerging...

Rekha Lakshmanan, M.H.A. is the Chief Strategy Officer for The Immunization Partnership, a non-profit organization educating about and advocating for immunizations. She has extensive experience working with state legislatures and successfully advocated for the passage of multiple pieces of...

Luigi Lay graduated in Chemistry in 1990 and was awarded a PhD in Chemical Sciences in 1994 at the University of Milan, working on the synthesis of Streptococcus pneumoniae capsular polysaccharide fragments. After an EU-funded post-doctoral fellowship in the research group of Prof. Richard...

Alexandre Le Vert is the Executive Chairman and Co-Founder of Osivax. Alexandre is a serial entrepreneur with a fascination for biology and more than 20 years of experience in healthcare ranging from research and development to commercialization of vaccines and therapeutics.He has led several...

Alessandro Manenti graduated in Biology obtaining his Bachelor’s Degree in 2009 and a Master’s Degree in Molecular Evolution in 2013 at the University of Siena. He worked for six months in a big company in the field of Life Sciences. In November 2013, he won a competition for PhD students in...

Former CMIO Kaiser Permanente, SCALLed digital transformation at Kaiser PermanentePhysician with deep experience in Internal Medicine, Critical Care, Trauma medicine, Hyperbaric medicine, Primary Care, Preventive Medicine, healthcare for the unhoused.CMIO, operating partner, ACPFounder CCD and CDA...

I am a Senior Advisor in R&D in GSK Vaccines, since 2018, and a GSK Fellow, since 2019. Prior to this I was the Global Head of Discovery Support and New Technology in GSK Vaccines. Until 2015, I was the Global Head of Vaccine Chemistry and Formulation Research for Novartis Vaccines. I have...

Dr. Masaru “Rusty” Oshita, is a board-certified Emergency Medicine physician with extensive experience in patient care and entrepreneurship. He runs a network of Urgent Care centers throughout Sacramento and is dedicated to providing thoughtfulmedical care in the community. Dr Oshita is recognized...

Mayur Patel, a distinguished executive, holds the role of Vice President of Global R&D Product Development and Portfolio Management at Elanco Animal Health. In this impactful position, he leads the crafting of a comprehensive global innovation strategy and oversees the R&D...

Gabriela Paz-Bailey, MD, PhD, MSc, DTM&H is the head of the Dengue Branch (DB) in the Vector-Borne Diseases Division (DVBD) of the National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), in San Juan , Puerto Rico. Dr. Paz-Bailey earned her degree in Medicine and Surgery from the ...

Amy Pisani, MS CEO Vaccinate Your Family Amy Pisani is a distinguished expert in the field of vaccine advocacy and education, with a remarkable tenure dating back to 1996 when she joined Every Child By Two (now known as Vaccinate Your Family). As the Chief Executive Officer, she has played a...

Bali Pulendran, PhD Violetta L. Horton Professor, and Co-Director. Institute for Immunity, Transplantation and Infection, Department of Pathology, Department of Microbiology and Immunology, Fellow at ChEM-H (Chemistry, Engineering and Medicine for Human Health), Stanford University School of...

Marlen Ramirez serves as Vaccinate Your Family’s Program Coordinator supporting VYF’s advocacy and education work. Marlen is an experienced Community Health Worker (CHW) and Community Health Worker Instructor (CHWI). She is a passionate advocate for health promotion and health equity, evidenced by...

Ruben Rizzi, physician by training, SVP of Global Regulatory Affairs at BioNTech. I joined the company in December 2019 just before the pandemic, and I have been the global regulatory lead for BioNTech for our COVID-19 development. Currently, I am still supporting the lifecycle of our COVID-19...

Angela K. Shen, ScD, MPH Adjunct Associate Professor in the School of Medicine and Senior Fellow at the Leonard Davis Institute of Health Economics University of Pennsylvania, and retired Captain in the US Public Health Service.  Dr. Shen is a vaccine policy expert and health services researcher...

Lora Shimp has over 30 years of experience in international development and maternal and child health, particularly in immunization program implementation and leadership. With her background in epidemiology, international primary health care, and communication and behavior change, Ms. Shimp has...

Jeffrey Skolnik, M.D. Senior Vice President, Clinical Development Dr. Skolnik leads INOVIO’s clinical development programs, focusing on HPV and immuno-oncology DNA medicines. He is a key member of the leadership team overseeing these global clinical assets.  Dr. Skolnik has held several leadership ...

Denise Octavia Smith, MBA, CHW, PN is the inaugural Executive Director of the National Association of Community Health Workers, Visiting Scholar at the Harvard Medical School Center for Primary Care Program in Global Primary Care and Social Change, Aspen Institute Healthy Communities Fellow, and a...

Dr. Snowden joined GlaxoSmithKline in 2015 where she has held both global and US medical affairs appointments. She currently serves as Medical Director, Vaccines Clinical & Medical Affairs, US for the adult RSV portfolio. Dr. Snowden holds bachelor’s degrees in biology and chemistry from Howard ...

Walter Straus is Vice President for Clinical Safety & Risk Management at Moderna. After joining Moderna in March 2021, he was charged with building and leading the team responsible for clinical safety and pharmacovigilance for the COVID-19 vaccine program. His current responsibilities include...

Thomas Tillett – Cofounder and CEO of MBF Therapeutics, an immunotherapeutics company that has developed and patented an innovative, proprietary T-Max™ DNA vaccine platform to deliver commercial protective vaccines that provide safe, durable, heterologous protection against endemic, emerging and...

Dr. Sean Tucker is the Founder of Vaxart and has served as its Chief Scientific Officer since February 2010.   From March 2004 to February 2010, Sean served as Vice President of Research and Director of Immunology.  He has held numerous scientific and engineering roles at various biotechnology...

Robert Allen, Ph.D. Chief Scientific Officer Robert Allen, Ph.D. has served as Chief Scientific Officer at Invivyd since April 2023. He hasover 30 years of experience across the infectious disease space, most recently as the Chief Scientific Officer of SmartPharm Therapeutics, a subsidiary of...

Shweta Bansal is Professor at the Department of Biology at Georgetown University. At Georgetown University, Dr. Bansal leads an interdisciplinary research group that develops data-driven mathematical models for human and animal disease systems using tools from network science, statistical...

Erwin Blomsma holds a Master’s degree in Bioscience Engineering and a Ph.D. in Applied Biological Sciences (1995) from KU Leuven in Belgium.  After post-doctoral studies at UCB he started his career at Janssen Pharmaceutica in 1996 in the Chemical Process Technology Group.  In 2000 he co-founded...

Michael Breen is a Scientist at Tiba Biotech. He joined Tiba after finishing his Ph.D. in Microbiology at Boston University in 2023 where he studied lung-resident B cell populations that arise after influenza virus infection. At Tiba, Michael has initiated multiple therapeutic and vaccine research...

Dr. Aaron Cowley is the Chief Scientific Officer (CSO) at ReciBioPharm (2019 to present), a leading Contract Development and Manufacturing Organization (CDMO) focused on Advanced Therapy Medicinal Products (ATMP), including but not limited to Live Biotherapeutic Products (LBPs), xRNA, pDNA and...

Dr. Kashmira Date is a physician, epidemiologist and global health leader with over 20 years of experience and leadership in both, public and private, sectors with clinical development/medical/scientific affairs in infectious diseases, vaccines, epidemiology, real-world evidence, pandemic...

Dr. William Decker is a Professor in the Department of Pathology & Immunology at Baylor College of Medicine. Dr. Decker received a B.S. in Biology from Tufts University and a Ph.D. in Molecular in Human Genetics from Baylor College of Medicine in 2001. Following early career work in...

Dr. Finn is University of Pittsburgh Distinguished Professor of Immunology and Surgery. After receiving her PhD in Medical Microbiology at Stanford University in 1980 and completing her postdoctoral training in Immuno-oncology there in 1982, Dr. Finn started her research at Duke University and in...

Dr. Douglas Gladue currently is an internationally recognized leader in bringing projects from concept to commercialization, with over 20 years of experience leading diverse research teams. As the Vice President for Veterinary Pharmaceutical Development at Seek Labs he leads a team to develop new...

Dr Tim Hirst is the Chairman and CEO of GPN Vaccines (https://gpnvaccines.com) an Australian biotechnology company conducting clinical trials of a new vaccine against the world’s foremost bacterial pathogen, Streptococcus pneumoniae. He is an entrepreneur, investor and internationally acclaimed...

I have always been interested in infectious diseases and approaches to prevent them, primarily with the application of vaccines, in both humans and Animals.I obtained my PhD in Virology from Harvard university in 2009 and before that I had my DVM from Addis Ababa University in Ethiopia and MSc in...

Alasdair King qualified as a veterinary surgeon from Glasgow University in 1990.  After 11 years in mixed practice he joined Intervet UK as livestock veterinary advisor.  Amongst other roles in the UK, he took on responsibility for company pharmacovigilance as the National PV Manager, and developed ...

Dr Prabuddha Kundu has a M.Tech, PhD in Biomedical Engineering from IIT Bombay, and specialized in protein therapeutics and scale up including MAbs. He has over 25 years of experience in various companies, and positions, including establishment of production facilities, for therapeutics and...

Alex Mann is a senior clinical scientist with over 25 years’ experience working in infectious and respiratory disease clinical research at hVIVO.He has significant expertise in leading the design, execution, and analysis of human challenge studies for efficacy testing, using pathogens such as...

Justine McPartlan, B.Sc., is a Scientist at Tiba Biotech. During her undergraduate research at MIT, she focused on novel RNA vaccine strategies to fight infectious disease and cancer at the Whitehead Institute for Biomedical Research under Dr. Hidde Ploegh. This work culminated in a 2016 PNAS...

Lisa Purcell has been an Entrepreneur-In-Residence at Third Rock Ventures since May 2024. Her career has been dedicated to the development of therapies within the immunology and infectious disease areas. During the COVID-19 pandemic, she co-chaired the ACTIV partnership established by the...

Dr. Hagen Richter joined WACKER in 2016 and currently serves as Director of Nucleic Acid Research with the WACKER central R&D hub in Munich, Germany. This team of approximately 30 scientific and technical experts focuses on research innovations and both academic and industry partnerships to...

Robert van der Put holds both a PhD in conjugate vaccine development and a master’s degree in drug innovation and has over 20 years of experience in the vaccine industry. He is a passionate and driven Director of Business Development at Intravacc, a leading CDMO for translational vaccinology. His...

Dr. Weiner research focuses on translational applications of molecular and cellular immunology utilizing invivo synthetic nucleic acid approaches.  His early work developed mAb as therapeutics targeting cancer (antigens) and for infectious disease targets.  His lab went on to be a founding research ...

Dr. Tom Campi is the CEO of Modulant Biosciences, an animal health biotechnology company focusing on therapies for infectious and chronic diseases. The current pipeline includes drugs for FIP, a fatal coronavirus in cats; Parvo, a serious enteric disease in dogs, PRRSv, a continuing problem for the ...

I direct the Laboratory of Malaria Immunology and Vaccinology, where research teams focus on pathogenesis, immunity, and vaccine development. I have extensive experience in human observational and interventional studies of malaria, including studies of controlled human malaria infections. As the...

Bernard Hoet is Vice President, Head of Medical strategy at Bavarian Nordic, a fully integrated pure-play vaccine company. He joined this company early 2020, at the time of acquisition of the rabies and tick-born encephalitis vaccines from GSK, to build up the Medical Affairs department, and...

Dr Ahmed OGWELL is currently the Vice President for Global Health Strategy at the United Nations Foundation (unfoundation.org). In this capacity he leads the broad portfolio of global health policy, advocacy, thought leadership and resource mobilizatiopn for key UN priority initiatives. He is a...

Dr. A. Selvapandiyan has been a prominent figure in vaccine development, with over 35 years of experience post-Ph.D. in molecular biology, focusing on molecular cell biology, diagnostics, immunology, and vaccinology. He has served as a Senior Research Scientist at the International Centre for...

Katie Van Tornhout is the founder of Callie Cares, a not-for-profit organization founded in 2010 that supports parents with hospitalized children and raises awareness about the seriousness of whooping cough (pertussis) and the importance of routine immunizations for pregnant people and children. ...

Tonya Colpitts is an accomplished professional with a proven track record in the global vaccine industry. Currently serving as Associate Vice President and Global Project Head for Vaccines at Sanofi, Tonya brings a wealth of experience and expertise to her role. With a strong background in research ...

Lisa Cornbrooks serves as the Senior Director, National Health Campaigns at AMGA Foundation. In this role, she oversees the Rise to Immunize® campaign, a six-year initiative that has engaged 85 medical groups and health systems across 30 states to improve routine adult immunization rates. She...

Sheetij Dutta leads the Structural Vaccinology Laboratory, Biologics Research and Development Branch at the Center for Infectious Disease Research, Walter Reed Army Institute of Research (WRAIR). SVL is engaged in discovery and development of vaccine and biologics against parasitic, bacterial and...

Joanie Robertson is a program advisor at PATH currently leading the portfolio on supply systems and equipment within the Medical Devices and Health Technologies program. A seasoned professional with over 30 years of work experience, including four years working for PATH in Vietnam (2009-2013) and...

Dr. Sardesai founded Geneos after building Inovio Pharmaceuticals into a Phase III cancer and infectious disease immunotherapy company serving as its Chief Operating Officer. He held positions of increasing responsibility after joining the company in 2006 where he helped formulate the company’s...

Previously, around 15 years of research program experience focused on novel drug development alongside pre-clinical modeling. Recently, utilizing scientific expertise to support national health care programs within HHS/OASH involving infectious diseases and disease prevention, including serving on...

Jorge Armero Gimenez is a key member of LenioBio’s Platform Development team, specializing in the advancement of recombinant protein vaccines utilizing the ALiCE® cell-free protein expression system.Jorge earned his PhD from Wageningen University & Research (WUR) in collaboration with LenioBio...

Jenna Benefield is a leader in McKinsey’s Pharmaceuticals & Medical Products Practice, serving clients across a variety of Strategy and Commercial topics – including revenue growth strategy, asset diligence, and physician/patient engagement. She co-leads the knowledge development for industry...

Marie Bonhomme, Ph.D., currently serves as Director of Labs at PPD, part of Thermo Fisher Scientific, where she provides strategic and operational oversight for the Vaccines Sciences Department within the Clinical Research Group. Dr. Bonhomme is known for her expertise in the field of Immunology...

Dr. Gabrielle Breugelmans is the Director of Epidemiology and Data Science at the Coalition for Epidemic Preparedness Innovations (CEPI). Her department's mission is to support CEPI, its partners, and stakeholders by bridging key epidemiological knowledge gaps critical for vaccine...

Dr. Bridges is a board-certified internal medicine physician who has worked on influenza and adult immunization issues for over 28 years.  She completed medical school at University of Washington, and internal medicine residency at University of Colorado.  After working as a primary care physician...

Dr. Buck received a bachelor’s degree in Molecular Cellular and Developmental Biology from the University of Colorado at Boulder. He then returned to his home state, Maryland, to earn a Ph.D. from the Johns Hopkins School of Medicine.  Dr. Buck’s graduate research in Dr. Robert Siliciano's lab...

Mia is the Director of Business Development at CRIO, an innovative company specializing in eSource technology. In her role, Mia works with sponsors, CROs, and sites to implement and optimize the CRIO solutions to drive greater efficiency in clinical trials. Mia leverages her expertise in technology ...

Maya Chandrasekaran is an applied economist who specializes in impact evaluations, global health, and ethical and effective survey-based research. She is the current director of the Mercury Project, a consortium of 18 research teams studying vaccine access and uptake, at the Social Science Research ...

Dr Ling CHEN received his medical degree from Shanghai Medical College in 1984. He received his PhD in Biochemistry and Molecular Biology from Indiana University School of Medicine, USA in 1992. Dr Chen completed his postdoctoral training in 1994 at the Dana-Farber Cancer Institute, Harvard Medical ...

Dr. Ghania Chikh, Senior Director, Vaccine Development, brings extensive experience to her senior leadership role at Acuitas Therapeutics, Inc. Dr. Chikh has spent much of her career working with vaccines and lipid nanoparticle (LNP) delivery technology. In fact, her PhD thesis was focused on...

Kati Chilikova is a Manager at Economist Impact, the insight and research arm of The Economist Group.  As Manager in the Health Practice, she leads diverse teams to design and deliver evidence-based health policy projects that tackle the world’s most pressing issues. She has experience in health...

Experienced Chief Executive Officer with a demonstrated history of working and succeeeding in the  biotechnology and medical technology industires.

Dr. Kyle Doolan leads cross-functional teams in molecular biology, protein engineering and virology that perform experiments for operations and research and development. Kyle has been instrumental in enhancing the performance of Integral Molecular’s technologies and is an inventor on two of the...

Susanne Eder-Lingelbach, MSc, MBA, is leading Valneva´s global Clinical Development organization based in Vienna, Austria and as Vice President a member of the company´s leadership team. Valneva is a public, fully integrated, specialty vaccine company focused on the development and...

Angela Eichler is currently the Director of Specialty Lab Services at Johnson County Clin-Trials (JCCT). Her expertise in isolation and cryopreservation of cell mediated immunity (CMI) samples spans over a decade. Ms. Eichler has worked extensively with pharmaceutical companies as well as...

Pernille Elverdal, PhD, has always been passionate about infectious diseases. She is known as an expert in this area with over 20 years of experience and a special focus on Pneumococcus, Legionella, Streptococcus and other bacteria causing respiratory diseases. Pernille is still a respected member...

Pascal Geldsetzer is an Assistant Professor of Medicine at Stanford University and a Chan Zuckerberg Biohub Investigator. He has won an NIH New Innovator Award to investigate the feasibility of applying causal effect estimation techniques from the social sciences to clinical research questions. As...

Michinari Hamaguchi earned his M.D. and Ph.D. in medicine from Nagoya University, then he pursued his research at Rockefeller University in the U.S (1985-1988). He served as the President of Nagoya University from April 2009 to March 2015 before becoming the President of the Japan Science and...

Jian (Jason) He has 18 years of vaccine development experience with growing responsibilities in vaccine R&D and commercialization of recombinant proteins, conjugates, and VLPs with Merck & Co., WuXi Biologics, and WuXi Vaccines. Jason received his B.S. in Chemistry from Peking...

Jennifer is a leader in McKinsey’s Pharmaceuticals & Medical Products Practice, and she serves pharmaceutical and high growth biotechnology companies on innovation and go-to-market strategies for biological therapeutics and vaccines. A scientist by training, Jennifer leads McKinsey’s knowledge...

Klaus Hellmann, DVM, is the Head of Europe CRO at Argenta, bringing extensive expertise in animal health product development. He has played a pivotal role in securing successful marketing authorisations for numerous products across various organisations. Klaus studied veterinary medicine at the...

Xuefei Huang is a MSU Foundation Professor at Michigan State University. He is a full professor jointly appointed in the Departments of Chemistry and Biomedical Engineering, as well as the Chief of the Chemical Biology Division of the Institute for Quantitative Health Science and Engineering. His...

Dr. Juan Carlos Jaramillo, MD, is a seasoned Research and Development leader with extensive expertise spanning medical affairs, clinical development, pharmacovigilance, regulatory affairs, market access, and pricing. As Chief Medical Officer at Valneva, he builds on a distinguished career holding...

Elizabeth Joseph has a B.S. in Chemistry from Indiana University, and is a Research Scientist II at Simtra BioPharma Solutions in Bloomington, IN.  She is a member of the Development and Pre-Commercial Services team, offering contract development services including formulation...

Elizabeth Linderbaum is Deputy Director of Regulatory Affairs at the National Association of Community Health Centers (NACHC). In this role, she leads the Federal regulatory portfolio, with her main policy areas of focus including the 340B drug pricing program, Medicare and Medicaid issues, as well ...

Sujatha Narayan, is the Principal Regulatory Program Director in Pharma Technical Regulatory at Genentech, a member of the Roche Group. In this role, Sujatha is responsible for ensuring regulatory compliance, conformance globally and effective issue management across all Chemistry, Manufacturing...

Dr. Nguh is a global health scholar and practitioner. His scope of practice has been in maternal newborn and child health programs, immunization, family planning and reproductive health, nutrition, health systems strengthening, water/sanitation/hygiene, malaria, prevention of mother-to-child...

Dr. May Pidding is currently the Director of Microneedle Array Patch (MAP) Product Management, where she serves as the global commercial focal point for LTS’s MAP portfolio.Dr. Pidding earned her Bachelor’s degree in Biology in 1993 from Boston University and completed her Ph.D. in Biomedical...

Dr. Robert Popovian is the Founder of the strategic consulting firm Conquest Advisors. He also serves as Chief Science Policy Officer at the Global Healthy Living Foundation, Senior Healthy Policy Fellow at the Progressive Policy Institute, and Visiting Health Policy Fellow at the Pioneer...

Dr. Kevin Russell is currently Section Head, Pediatric Vaccines, Global Clinical Development, at Merck Research Laboratories in Upper Gwynedd PA, after serving as Section Head for the Adult and Adolescent Vaccines Section from 2016 to 2022.  Before September 2016, Dr. Russell served as the US...

Tyler Sandberg is a scientist holding a PhD in vaccine immunology from the Karolinska Institute and a master’s degree in immunology and infection biology from Uppsala University. His doctoral research involved conducting several vaccine studies to examine human immune responses to various...

Dr. Giuseppe Sautto is Assistant Professor at the Cleveland Clinic Florida Research and Innovation Center. His main expertise is focused on antibody discovery and characterization, especially for infectious diseases-associated pathogens, including hypervariable, respiratory...

Hanneke Schuitemaker, Ph.D., has been Valneva’s Chief Scientific Officer since June 2024 and, as such, responsible for the pre-clinical and translational R&D and CMC strategy and execution, working on prophylactic vaccines against chikungunya, Lyme disease, Zika, Shigella, EBV and ETEC. Prior...

Joachim Seipelt is an experienced biotech manager with a strong background in virology and vaccine development. He has experience in research (Boehringer Ingelheim, Max Perutz Labs Vienna), company co-founding (AVIR Green Hills Biotechnology), managing large governmental funding programs (Austria...

Jon Snyder is a Senior Advisor in Elanco’s External Innovation team, where he seeks to bridge internal and external scientific opportunities with academic, biotech, and large pharma partners.  Prior to joining the External Innovation Team, Jon spent 8 years leading Elanco’s Discovery Biologics and...

Martín Solórzano is a Mexican medical doctor and public health expert with extensive experience leading health programs in Mexico and Spain, focusing on vulnerable populations. A former Mexican Youth Delegate to the United Nations, he has collaborated with international organizations on public...

Katy Stein is a Virology Scientist with Microbiologics.  She has a Ph.D in Biomedical Sciences from Icahn School of Medicine and Post Doctoral experience from Scripps Research and The Rockefeller University.  Katy has extensive expertise in virology, AAV delivery, and host-microbe...

Katarina Stenklo brings over 20 years of industry experience to her role as Product Manager for the FlexFactory manufacturing platform at Cytiva. She understands the critical importance of having a holistic view of biomolecule manufacturing. With extensive expertise in developing end-to-end...

Dr. Vianney Tricou is a clinical development and medical affairs professional with expertise in infectious diseases. Holding a PharmD from the University of Lyon and a PhD from the University of Oxford, he has gained extensive experience working in Asia and Africa with leading academic...

Isaac is a Senior Analyst at Airfinity, currently working in the respiratory infectious disease vaccines team. Before joining Airfinity, Isaac graduated from the University of Oxford with a degree in Cell & Systems biology, focusing on immunology and genetics. Since joining Airfinity in...

Roland Ventura holds a PhD in molecular biology and vaccines from the Queen’s University Belfast.  After postdoctoral training at the University of Oxford he worked with Dako A/S in Denmark under a European Commission-funded Marie Curie Transfer of Knowledge Fellowship.  Following this, he became...

Felipe Villalobos is a medical doctor graduated from the Universidad Autonoma Metropolitana in Mexico. Currently, he is a primary care researcher at the IDIAP Jordi Gol pin Barcelona, Spain, with a line of research in health promotion and preventive activities. Last five years, he has been...

Kelly Warfield, PhD, joined the Sabin Vaccine Institute as its President of Research & Development in August 2024. In this role, Kelly collaborates with executive team members, cross-functional leaders, and the Board of Trustees to drive Sabin’s strategic vision, manage and grow the R&D...

Alan John Young, PhD Chief Scientific Officer, VST/Medgene Labs LLC, Professor and Research Leader, Department of Veterinary and Biomedical Sciences South Dakota State University Dr. Young?s career has focused on the application of domestic animal models to biomedical applications.  Dr. Young...

A medical doctor and infectious disease epidemiologist, Dr Seth Berkley is currently serving as an advisor and Board member to numerous health and technology companies and is an Adjunct Professor at the Pandemic Center at Brown University.  He previously was CEO of Gavi, the Vaccine Alliance from...

Dr. Robert T Chen has been active in research of vaccines and vaccine-preventable diseases for over 40 years, mostly at the US Centers for Disease Control and Prevention (CDC).  He played key roles in modernizing the vaccine safety infrastructure in the U.S. and elsewhere, including the creation of ...

Peter is Deputy Director for Integrated Clinical Vaccine Development within the Global Health Division at the Gates Foundation.  In this role, he provides technical and strategic guidance on clinical development to the foundation’s program strategy teams.  His group works on accelerating vaccine...

Dr. Richard E. Hill, Jr., (Rick) received a D.V.M. degree from Michigan State University in 1983 and following graduation, worked in private veterinary practice. In 1985, he joined the USDA and spent the majority of his career working in the Biologics Program as an Inspector, Epidemiologist, and...

As Chief Scientific Officer, Michael is responsible for LimmaTech’s scientific development, focusing on pipeline development and operational R&D performance. Michael has a PhD in Biochemistry from the Swiss Federal Institute of Technology, Zurich (ETH Zurich) and developed a broad experience in ...

Robert Sitrin, PhD, is a Bioanalytical leader with a 35+ year career at Merck and GSK in vaccine R&D, registration, manufacturing, and process improvements.  He built effective downstream process and bioanalytical departments to support the licensure of nine new...

Dr Chaiken is an industry veteran with global expertise following a 23-year career at Pfizer where she held senior executive roles, including Chief Medical Officer for the company’s Biopharmaceutical Group for Emerging Markets. In this role, Dr Chaiken built a high-performing medical affairs...

Christian W. Mandl is a consultant for industrial, academic and non-profit organizations on translational aspects of vaccines, cancer immunotherapy and global health. His engagement with the health care industry and public health organizations includes roles as Co-founder and Chief Scientific...